Back to results
US 2012/0252877 A1Published application
Methods and compositions for treatment of tuberous sclerosis complex
AssigneeTheramind Research, LLC
InventorLoon-Tzian Lo
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to a method of treating Tuberous Sclerosis Complex (TSC). The present disclosure further provides an isolated polynucleotide molecule comprising, a polynucleotide comprising an AAV9 vector; a polynucleotide encoding a TSC1 or a TSC2, or variant thereof; and a promoter. The present disclosure further provides a pharmaceutical composition comprising an isolated polynucleotide molecule.
Claims24
A method of treating Tuberous Sclerosis Complex (TSC), the method comprising
- administering to a subject in need thereof a therapeutically effective amount of a composition comprising an adeno-associated virus (AAV) vector, the AAV vector comprising at least one polynucleotide encoding a TSC1 or a TSC2, or variant thereof;
- wherein TSC1 or TSC2 is expressed in a plurality of cells of the subject.
An isolated polynucleotide molecule comprising:
- (i) a polynucleotide comprising an AAV9 vector;
- (ii) a polynucleotide encoding a TSC1 or a TSC2, or variant thereof;
- and
- (iii) a promoter;
- wherein the promoter is operably linked to the polynucleotide encoding a TSC1 or a TSC2, or variant thereof.
2 more elements
Dependencies are inferred from the claim text.